PHARMACOECONOMIC EVALUATION OF POMALIDOMIDE (IMNOVID) FOR THE TREATMENT OF RECURRENT AND REFRACTORY MULTIPLE MYELOMA by M. Yu. Frolov, O. V. Shatalova

Get full text

PHARMACOECONOMIC STUDY OF LENVIMA (LENVATINIB) IN ADVANCED PROGRESSIVE RADIO IODINE REFRACTORY DIFFERENTIATED THYROID CANCER IN THE RUSSIAN FEDERATION by M. Yu. Frolov, V. A. Rogov

Get full text

CLINICAL AND ECONOMIC EVALUATION OF LACOSAMIDE IN PATIENTS WITH PARTIAL EPILEPSY by E. A. Pyadushkina, M. Yu. Frolov

Get full text

PHARMACOECONOMIC ANALYSIS OF VESOMNI (SOLIFENACIN AND CONTROLLED RELEASE TAMSULOSIN) TREATMENT OF STORAGE SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA by N. A. Avxentyev, M. Yu. Frolov

Get full text

EVALUATION OF DRUG THERAPY IN PROGRESSING DIFFERENTIATED THYROID CANCER REFRACTORY TO RADIOACTIVE IODINE IN PATIENTS RESIDING IN THE RUSSIAN FEDERATION : PHARMACOECONOMIC ASPECTS by M. Yu. Frolov, V. A. Rogov

Get full text

PHARMACOECONOMIC JUSTIFICATION OF A WIDER USE OF PREVENTIVE HEMOPHILIA THERAPY IN THE RUSSIAN FEDERATION by M. Yu. Frolov, V. A. Rogov

Get full text

Dupilumab in the treatment of severe non-control broncial asthma — economic aspects by A. S. Salasyuk, M. Yu. Frolov, I. N. Barykina

Get full text

Direct medical costs of using enzalutamide or abiraterone in chemotherapy-naïve patients with metastatic castration resistant prostate cancer by N. A. Avxentyev, A. S. Makarov, M. Yu. Frolov

Get full text

Pharmacoeconomic analysis of treatment with nilotinib as the second line therapy in patients with chronic myeloid leukemia by N. A. Avxentyev, M. Yu. Frolov, A. S. Makarov

Get full text

Evaluation of the economic effect of biological therapy in patients with severe COVID-19 and cytokine storm by M. Yu. Frolov, A. S. Salasyuk, V. A. Rogov

Get full text

Pharmacoeconomic analysis of using cyclin-dependent kinase 4 and 6 inhibitors in the first line treatment of HR-positive HER2-negative advanced breast cancer by N. A. Avxentyev, E. V. Lubennikova, M. Yu. Frolov

Get full text

The calculation algorithm of oil and gas production enterprise energy efficiency indicators by A. Yu. Arestova, V. N. Ulyanov, M. Yu. Frolov

Get full text

CLINICAL AND ECONOMIC EVALUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN THE TREATMENT OF CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA IN ADULTS by E. A. Pyadushkina, M. Yu. Frolov, M. V. Avksentyeva

Get full text

Estimating long-term overall survival with olaparib as maintenance therapy in patients with newly diagnosed advanced ovarian cancer with BRCA mutations by N. A. Avxentyev, S. V. Khokhlova, M. Yu. Frolov, A. S. Makarov

Get full text

PHARMACOECONOMIC ANALYSIS OF EVEROLIMUS IMMUNOSUPRESSIVE THERAPY AFTER RENAL TRANSPLANTATION by M. V. Avxentyeva, N. A. Avxentyev, M. Yu. Frolov, E. V. Derkach

Get full text

Evaluation of the health care budget impact of secukinumab treatment in patients with ankylosing spondylitis by S. K. Zyryanov, I. N. Dyakov, S. V. Nedogoda, M. Yu. Frolov, A. S. Salasyuk

Get full text

Self-care as the Basis of the Mobile Application for Patients with Chronic Coronary Syndromes by A. I. Laskova, M. Yu. Frolov, Yu. A. Orlova, Yu. M. Lopatin

Get full text

Pharmacoeconomic analysis of thrombopoietin receptor agonists in the treatment of chronic idiopathic thrombocytopenic purpura in adults by E. A. Pyadushkina, M. Yu. Frolov, V. A. Shuvaev, V. A. Rogov

Get full text

Economic evaluation of the fixed combination of insulin glargine and lixisenatide in Diabetes Mellitus type 2 by S. V. Nedogoda, A. S. Salasyuk, I. N. Barikina, V. O. Smirnova, M. Yu. Frolov

Get full text

Pharmacoeconomic analysis of tiotropium bromide and olodaterol fixed combination as maintenance therapy for patients with COPD in the Russian Federation by S. V. Nedogoda, M. Yu. Frolov, A. S. Salasyuk, I. N. Barykina, V. O. Smirnova

Get full text